Your browser doesn't support javascript.
loading
A model-informed approach to accelerate the clinical development of cofrogliptin (HSK7653), a novel ultralong-acting dipeptidyl peptidase-4 inhibitor.
Cui, Cheng; Cao, Fangrui; Kong, Iok Ian; Wu, Qinghe; Li, Fangqiong; Li, Haiyan; Liu, Dongyang.
Afiliação
  • Cui C; Geriatrics Department, Peking University Third Hospital, Beijing, China.
  • Cao F; Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.
  • Kong II; Center of Clinical Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing, China.
  • Wu Q; Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.
  • Li F; Center of Clinical Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing, China.
  • Li H; School of Pharmaceutical Sciences, Tsinghua University, Beijing, China.
  • Liu D; School of Pharmacy, Faculty of Medicine, Macau University of Science and Technology, Macau SAR, China.
Diabetes Obes Metab ; 26(2): 592-601, 2024 Feb.
Article em En | MEDLINE | ID: mdl-37953687
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV Limite: Humans Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV Limite: Humans Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China